AstraZeneca competitors

AstraZeneca Competitors include Bristol-Myers Squibb, Bayer, Roche and XOMA.
Add company...
AstraZeneca
AstraZeneca
AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bayer
Bayer
Bayer is a multinational pharmaceutical and life sciences company.
Roche
Roche
Roche Holding is a diagnostics and pharmaceutical company.
XOMA
XOMA
XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.
Founding Date
Founding Date
1999
Founding Date
1887
Founding Date
1863
Founding Date
1896
Founding Date
1981
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Sydney, AU
Brussels, BE
Fredericton, CA
Hamilton, CA
Mississauga, CA
Montreal, CA
see more
Locations
New York, US HQ
Vienna, AT
Braine L'alleud, BE
Calgary, CA
Edmonton, CA
Montreal, CA
Toronto, CA
see more
Locations
Leverkusen, DE HQ
Pymble, AU
São Paulo, BR
Mississauga, CA
Shanghai, CN
Havana, CU
Guatemala, GT
see more
Locations
Basel, CH HQ
South San Francisco, US
Locations
Emeryville, US HQ
Employees
Employees
61,100
Employees
23,700
Employees
99,820
Employees
93,734
Employees
1878% decrease
Valuation ($)
Valuation ($)
97.2 b
Valuation ($)
83.1 b
Valuation ($)
113.3 b
Valuation ($)
N/A
Valuation ($)
118.7 m
Twitter followers
Twitter followers
141.3 k
Twitter followers
120.8 k
Twitter followers
148.9 k
Twitter followers
177.2 k
Twitter followers
185

Financial

Revenue (est.)
Revenue (est.)
£22.5b (FY, 2017)
Revenue (est.)
$20.8b (FY, 2017)
Revenue (est.)
€35b (FY, 2017)
Revenue (est.)
CHF48.1b (FY, 2015)
Revenue (est.)
$52.7m (FY, 2017)
Cost of goods
Cost of goods
£4.3b (FY, 2017)
Cost of goods
$6.1b (FY, 2017)
Cost of goods
€11.4b (FY, 2017)
Cost of goods
CHF15.5b (FY, 2015)
Cost of goods
N/A
Gross profit
Gross profit
£18.1b (FY, 2017)
Gross profit
$14.7b (FY, 2017)
Gross profit
€23.6b (FY, 2017)
Gross profit
CHF32.7b (FY, 2015)
Gross profit
N/A
Net income
Net income
£2.9b (FY, 2017)
Net income
$975m (FY, 2017)
Net income
€8.1b (FY, 2017)
Net income
CHF9.1b (FY, 2015)
Net income
N/A

Operating

Countries
Countries
100 (FY, 2016)
Countries
N/A
Countries
152 (FY, 2016)
Countries
N/A
Countries
N/A
Drugs Approved by FDA
Drugs Approved by FDA
1 (FY, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
2 (Y, 2015)
Drugs Approved by FDA
N/A
Phase III Trials Products
Phase III Trials Products
27 (FY, 2016)
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
17 (FY, 2015)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
132 (FY, 2016)
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Bristol-Myers Squibb
HQ
New York, US
Employees
23,700

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

View company
Bayer
HQ
Leverkusen, DE
Employees
99,820

Bayer is a multinational pharmaceutical and life sciences company.

View company
Roche
HQ
Basel, CH
Employees
93,734

Roche Holding is a diagnostics and pharmaceutical company.

View company
XOMA
HQ
Emeryville, US
Employees
18

XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.

View company